Diabetes Center at UCSF - NON DIABETICS: AGE 20 TO 50, NOT EXERCISING REGULARLY AND OF NORMAL BODY WEIGHT (Chromium)

Diabetes Endocrinology Research Center (DERC)

DERC was established to support and enhance interactions among an outstanding team of investigators involved in Type 1 or 2 diabetes research.

UCSF JDRF CENTER (CCCT)

The mission of the center is to develop and test a new approach to the treatment of Type 1 diabetes by bringing together researchers from 5 academic institutions and 1 commercial partner.

NON DIABETICS: AGE 20 TO 50, NOT EXERCISING REGULARLY AND OF NORMAL BODY WEIGHT (Chromium)

CHROMIUN AND INSULIN RESISTANCE STUDY

Investigators at the University of California, San Francisco are interested in finding out the effect of chromium therapy on insulin resistance.

Who can sign up for this study?
To be eligible, you must be a healthy 20 to 50 year old non-diabetic, not exercising regularly and of normal body weight.

What will happen in this study?
All subjects will undergo blood and muscle tests to determine if they are insulin resistant or insulin sensitive. Subjects who qualify will also receive either chromium therapy or a placebo (inactive substance) for 16 weeks. UCSF will study the results of chromium on body fat and muscle function.

How long will this study last?
Each participant will be followed for 16 weeks.

Reimbursement: You will be paid up to $500 for your time, effort and travel expenses.

If you are interested in this study or have any questions, please contact the Study Coordinator, Shelley McCoy at 415-353-9087 or email at shmccoy@medicine.ucsf.edu.

Printer Friendly